Bacterial Gastroenteritis Clinical Trials

Find Bacterial Gastroenteritis Clinical Trials Near You

Antimicrobial Stewardship Effects of Interpretive Comments for Faecal PCR Tests

Status: Recruiting
Location: See all (4) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Bacterial gastroenteritis is a common condition seen in Aotearoa New Zealand, which is typically diagnosed by PCR testing on a stool sample. Most causes of bacterial gastroenteritis (e.g. Campylobacter spp, Salmonella spp, Yersinia spp) cause a self-limiting illness and antibiotic therapy is not required. Indeed, guidelines available for community healthcare providers in Aotearoa (e.g. Community HealthPathways, recently released national antimicrobial guidelines Te Whata Kura) recommend against antibiotic therapy for the vast majority of cases. A recent internal analysis at Awanui Laboratories of community faecal pathogen PCR testing revealed that antibiotic prescribing was very common after a positive result (ranging between 20-40% for the various individual pathogens), which suggests many community healthcare providers may not be following the recommended approach for the management of these infections. Given how common infectious gastroenteritis is in Aotearoa, and the volume of tests performed (approximately 100,000 through the Awanui network per year), this prescribing behaviour may represent a large volume of unnecessary antibiotic use in our communities, with resultant potential harmful effects at the individual patient level and population level via side effects, disruption to the faecal microbiome, and impacts on antimicrobial resistance (AMR). In previous work we have demonstrated that interpretive comments, when added to laboratory reports, can have a significant positive effect on prescriber behaviour (https://doi.org/10.1093/jac/dkad384), but this has not been examined in relation to faecal pathogen testing.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 6 months
Healthy Volunteers: f
View:

• Age over six months

• Stool sample submitted to Awanui Labs for faecal bacterial pathogen testing from a community health provider during the study period

• Test results report the detection of: Campylobacter spp, Shigella spp/Entero-invasive Escherichia coli, Salmonella spp, Yersinia spp, or Aeromonas spp.

Locations
Other Locations
New Zealand
Awanui Labs Auckland
RECRUITING
Auckland
Awanui Labs Christchurch
RECRUITING
Christchurch
Awanui Labs Dunedin
RECRUITING
Dunedin
Awanui Labs Wellington
RECRUITING
Wellington
Contact Information
Primary
Max Bloomfield, MBChB
maxim.bloomfield@ccdhb.org.nz
+64272089584
Time Frame
Start Date: 2026-06-02
Estimated Completion Date: 2027-09-17
Participants
Target number of participants: 10000
Treatments
Active_comparator: Interpretive laboratory comment - guideline
Interpretive comment with advice to follow local guidelines
Active_comparator: Interpretive laboratory comment - guideline + population harms
Interpretive comment with advice to follow local guidelines PLUS comment about population level harms of antibiotic overuse (i.e. AMR)
Active_comparator: Interpretive laboratory comment - guideline + individual harms
Interpretive comment with advice to follow local guidelines PLUS comment about individual patient harms of antibiotic overuse (e.g. side effects)
No_intervention: Control
No comment added to lab report
Sponsors
Leads: Medical Research Institute of New Zealand
Collaborators: Awanui Labs

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

We couldn't find any related articles check for more on the main search page.